Katherine Eade, JD

Katherine Eade is Chief Legal Officer of Kriya. She is an independent board member for Harvard Bioscience and is the chairperson of the Governance committee and a member of both the Audit and Com­pen­sa­tion committees. Katherine joined Kriya after serving as a consulting General Counsel and advisor to biopharma companies for fundraising, corporate governance, board matters, and BD and licensing oppor­tu­ni­ties. Prior to this, Katherine was General Counsel of Checkmate Phar­ma­ceu­ti­cals & President of Checkmate Phar­ma­ceu­ti­cals Security Corp. where, along with leading legal, IP and compliance, she negotiated strategic agreements including co-leadership of the sale of Checkmate to Regeneron Phar­ma­ceu­ti­cals. In the decade prior to joining Checkmate, Katherine served in various legal leadership roles, including VP of Strategic Commercial Affairs at Align Technology, Director of M&A Law & Trans­ac­tions at Corning Incor­po­rat­ed, and Division Counsel of Corning Life Sciences and Corning Phar­ma­ceu­ti­cal Tech­nolo­gies. Katherine began her legal career as an attorney at Cleary Gottlieb, a leading inter­na­tion­al law firm, and served as a law clerk to Judge Morton I. Greenberg of the U.S. Court of Appeals for the Third Circuit. Katherine received a JD from Harvard Law School and a BA from Cornell University.